These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1651082)

  • 41. Superoxide radical production during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium perchlorate.
    Zang LY; Misra HP
    J Biol Chem; 1992 Sep; 267(25):17547-52. PubMed ID: 1325439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A catalyst function for MPTP in superoxide formation.
    Poirier J; Barbeau A
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1284-9. PubMed ID: 2996546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.
    Ulanowska K; Piosik J; Gwizdek-Wiśniewska A; Wegrzyn G
    Bioorg Med Chem; 2007 Aug; 15(15):5150-7. PubMed ID: 17533133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent.
    Johannessen JN; Adams JD; Schuller HM; Bacon JP; Markey SP
    Life Sci; 1986 Feb; 38(8):743-9. PubMed ID: 3485234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites.
    Cashman JR
    Toxicology; 1987 Feb; 43(2):173-82. PubMed ID: 2949395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
    Nicklas WJ; Vyas I; Heikkila RE
    Life Sci; 1985 Jul; 36(26):2503-8. PubMed ID: 2861548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase.
    Sinha BK; Singh Y; Krishna G
    Biochem Biophys Res Commun; 1986 Mar; 135(2):583-8. PubMed ID: 3008728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
    Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.
    Wu EY; Chiba K; Trevor AJ; Castagnoli N
    Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
    Herraiz T; Guillén H; Galisteo J
    Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Participation of manganese-superoxide dismutase in the neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity.
    Alcaraz-Zubeldia M; Montes S; Ríos C
    Brain Res Bull; 2001 May; 55(2):277-9. PubMed ID: 11470327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of N-methylmercaptoimidazole on the disposition of MPTP and its metabolites in mice.
    Chiba K; Horii H; Kubota E; Ishizaki T; Kato Y
    Eur J Pharmacol; 1990 May; 180(1):59-67. PubMed ID: 2365003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity.
    Frank DM; Arora PK; Blumer JL; Sayre LM
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1095-104. PubMed ID: 3499150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances.
    Sayre LM; Wang FJ; Arora PK; Riachi NJ; Harik SI; Hoppel CL
    J Neurochem; 1991 Dec; 57(6):2106-15. PubMed ID: 1940917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
    Riachi NJ; Harik SI; Kalaria RN; Sayre LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its toxic metabolites on the physicochemical property of the liposomal membrane in relation to their cytochrome P-450 inhibition.
    Das NP; Shahi GS; Moochhala SM; Sato T; Sunamoto J
    Chem Phys Lipids; 1992 Oct; 62(3):303-10. PubMed ID: 1468127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.